Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Tiziana Life Sciences Ltd (TLSA)

Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 100,390
  • Shares Outstanding, K 105,396
  • Annual Sales, $ 0 K
  • Annual Income, $ -17,690 K
  • EBIT $ 0 M
  • EBITDA $ -18 M
  • 60-Month Beta 0.63
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 51.13
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/09/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 453.28% ( -8.96%)
  • Historical Volatility 104.53%
  • IV Percentile 82%
  • IV Rank 57.52%
  • IV High 754.05% on 05/14/24
  • IV Low 46.05% on 10/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 18
  • Volume Avg (30-Day) 54
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 1,647
  • Open Int (30-Day) 1,546

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8701 +8.61%
on 11/06/24
1.2700 -25.59%
on 11/11/24
+0.0077 (+0.82%)
since 11/01/24
3-Month
0.7700 +22.73%
on 09/06/24
1.2700 -25.59%
on 11/11/24
-0.0550 (-5.50%)
since 08/30/24
52-Week
0.4100 +130.49%
on 04/15/24
1.7400 -45.69%
on 08/12/24
+0.3500 (+58.82%)
since 12/01/23

Most Recent Stories

More News
Tiziana Life Sciences Receives ALS Association Grant to Advance Clinical Trial of Intranasal Foralumab for ALS Treatment

Tiziana Life Sciences receives funding from the ALS Association for a clinical trial of intranasal foralumab in ALS patients.Quiver AI SummaryTiziana Life Sciences, a biotechnology company focused on immunomodulation...

TLSA : 0.9450 (-0.79%)
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises

EQNX::TICKER_START (NASDAQ:TLSA),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:BIIB),(NASDAQ:TGTX) EQNX::TICKER_END

TLSA : 0.9450 (-0.79%)
LLY : 799.80 (+0.56%)
RHHBY : 36.0800 (-0.44%)
BIIB : 164.23 (+2.24%)
TGTX : 35.09 (+0.83%)
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises

TLSA : 0.9450 (-0.79%)
LLY : 799.80 (+0.56%)
RHHBY : 36.0800 (-0.44%)
BIIB : 164.23 (+2.24%)
TGTX : 35.09 (+0.83%)
Gevo's Cash Flow, Small Cap Buying Back Shares

GEVO shareholders may have been sold an empty promise of a sizable share buyback program, or so would bears say. Revenue breakthroughs may deliver the promise

TLSA : 0.9450 (-0.79%)
GEVO : 1.5800 (-4.24%)
TSLA : 357.09 (+3.46%)
NIO Could Bring A Pleasant Beat This Coming Quarter

Tesla's price cuts have initiated a full on war across the EV industry, however NIO has refused to follow along. This may present even more upside for the stock

TLSA : 0.9450 (-0.79%)
NIO : 4.40 (-1.79%)
TSLA : 357.09 (+3.46%)
LCID : 2.13 (-2.29%)
RIVN : 11.87 (-2.94%)
TCEHY : 51.5500 (-0.10%)
BYDDF : 33.6350 (+2.08%)
Tiziana Life Sciences Appoints Matthew W. Davis, MD, RPh as Chief Medical Officer and Acting Chief Scientific Officer

NEW YORK, July 18, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling...

TILS.LN : 58.500 (+8.33%)
TLSA : 0.9450 (-0.79%)
Tiziana Life Sciences Announces Resignation of CEO

NEW YORK, July 15, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd.(Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling...

TILS.LN : 58.500 (+8.33%)
TLSA : 0.9450 (-0.79%)
Tiziana Life Sciences Ltd. Receives Nasdaq Deficiency Notice

NEW YORK, June 17, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling...

TLSA : 0.9450 (-0.79%)
TILS.LN : 58.500 (+8.33%)
Tiziana Life Sciences Announces Purchase of Common Shares by Executive Chairman

NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd.(Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling...

TILS.LN : 58.500 (+8.33%)
TLSA : 0.9450 (-0.79%)
Tiziana Life Sciences PLC (TLSA: NASDAQ) Releases Research Report: Clinical Improvements for 2nd SPMS Patient

Zacks Small-Cap Research Note By John D. Vandermosten, CFA NEW YORK, June 09, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences PLC (NASDAQ: TLSA)...

TILS.LN : 58.500 (+8.33%)
TLSA : 0.9450 (-0.79%)

Business Summary

Tiziana Life Sciences PLC is a biotechnology company. It focuses on the clinical development for the treatment of cancers, chronic inflammatory and autoimmune neurodegenerative disorders. The company's product pipeline consists of Foralumab TZLS-401 and Milciclib TZLS-201 which are in clinical stage....

See More

Key Turning Points

3rd Resistance Point 0.9867
2nd Resistance Point 0.9683
1st Resistance Point 0.9567
Last Price 0.9450
1st Support Level 0.9267
2nd Support Level 0.9083
3rd Support Level 0.8967

See More

52-Week High 1.7400
Fibonacci 61.8% 1.2319
Fibonacci 50% 1.0750
Last Price 0.9450
Fibonacci 38.2% 0.9181
52-Week Low 0.4100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar